vimarsana.com
Home
Live Updates
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S..
Related Keywords
Frankfurt ,
Brandenburg ,
Germany ,
United States ,
Fernando Beils ,
Us National Institutes Of Health ,
Drug Administration ,
Frankfurt Prime Standard ,
Neumodx Molecular Systems ,
Senior Vice President ,
Molecular Diagnostics Business Area ,
Assay ,
It ,
Chlamydia ,
Iagnostics ,
Wood ,
Dvd ,